Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 46 | $19,278,733 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 10 Mar 2025 12:53 | RARE | Ultragenyx Pharmaceutical Inc | HORN HOWARD | Chief Financial Officer | 06 Mar 2025 | Sale | 1,785 | 40.4 | 72,114 | D |
| 04 Mar 2025 20:19 | RARE | Ultragenyx Pharmaceutical Inc | KASSBERG THOMAS RICHARD | CBO & EVP | 03 Mar 2025 | Sale | 6,028 | 42.1 | 253,779 | D |
| 04 Mar 2025 20:18 | RARE | Ultragenyx Pharmaceutical Inc | PARSCHAUER KARAH HERDMAN | EVP and Chief Legal Officer | 03 Mar 2025 | Sale | 12,846 | 42.1 | 540,817 | D |
| 04 Mar 2025 20:16 | RARE | Ultragenyx Pharmaceutical Inc | CROMBEZ ERIC | EVP and Chief Medical Officer | 03 Mar 2025 | Sale | 8,945 | 42.1 | 376,584 | D |
| 04 Mar 2025 20:12 | RARE | Ultragenyx Pharmaceutical Inc | PINION JOHN RICHARD | See Remarks | 03 Mar 2025 | Sale | 14,439 | 42.1 | 607,882 | D |
| 04 Mar 2025 20:10 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 03 Mar 2025 | Sale | 73,434 | 42.1 | 3,091,571 | D |
| 04 Mar 2025 20:10 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 28 Feb 2025 | Sale | 25,000 | 42.48 | 1,062,000 | I |
| 04 Mar 2025 20:06 | RARE | Ultragenyx Pharmaceutical Inc | HARRIS ERIK | EVP & Chief Commercial Officer | 03 Mar 2025 | Sale | 15,103 | 42.1 | 635,836 | D |
| 04 Mar 2025 20:00 | RARE | Ultragenyx Pharmaceutical Inc | HUIZENGA THEODORE ALAN | SVP, Chief Accounting Officer | 03 Mar 2025 | Sale | 967 | 42.1 | 40,711 | D |
| 03 Mar 2025 13:58 | RARE | Ultragenyx Pharmaceutical Inc | PARSCHAUER KARAH HERDMAN | EVP and Chief Legal Officer | 27 Feb 2025 | Sale | 2,230 | 42.93 | 95,734 | D |
| 03 Mar 2025 13:58 | RARE | Ultragenyx Pharmaceutical Inc | PARSCHAUER KARAH HERDMAN | EVP and Chief Legal Officer | 27 Feb 2025 | Sale | 760 | 42.75 | 32,490 | D |
| 31 Dec 2024 14:05 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 30 Dec 2024 | Sale | 11,727 | 42.23 | 495,231 | I |
| 11 Dec 2024 18:44 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 10 Dec 2024 | Sale | 8,273 | 50 | 413,650 | I |
| 11 Oct 2024 16:48 | RARE | Ultragenyx Pharmaceutical Inc | HORN HOWARD | Chief Financial Officer | 10 Oct 2024 | Sale | 7,465 | 52.76 | 393,853 | D |
| 05 Sep 2024 11:53 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 03 Sep 2024 | Sale | 20,000 | 55.85 | 1,117,000 | I |
| 05 Sep 2024 11:50 | RARE | Ultragenyx Pharmaceutical Inc | HUIZENGA THEODORE ALAN | SVP, Chief Accounting Officer | 03 Sep 2024 | Sale | 91 | 56.19 | 5,113 | D |
| 07 Aug 2024 14:48 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 06 Aug 2024 | Sale | 20,000 | 50.17 | 1,003,400 | I |
| 03 Jul 2024 14:07 | RARE | Ultragenyx Pharmaceutical Inc | SANDERS CORAZON (CORSEE) D. | Director | 02 Jul 2024 | Sale | 584 | 40.98 | 23,932 | D |
| 12 Jun 2024 19:47 | RARE | Ultragenyx Pharmaceutical Inc | PARSCHAUER KARAH HERDMAN | EVP and Chief Legal Officer | 12 Jun 2024 | Sale | 9,806 | 45 | 441,270 | D |
| 10 Jun 2024 19:58 | RARE | Ultragenyx Pharmaceutical Inc | SANDERS CORAZON (CORSEE) D. | Director | 10 Jun 2024 | Sale | 1,737 | 41.1 | 71,391 | D |
| 03 May 2024 15:23 | RARE | Ultragenyx Pharmaceutical Inc | CROMBEZ ERIC | EVP and Chief Medical Officer | 02 May 2024 | Sale | 354 | 43.66 | 15,456 | D |
| 19 Apr 2024 16:35 | RARE | Ultragenyx Pharmaceutical Inc | CROMBEZ ERIC | EVP and Chief Medical Officer | 18 Apr 2024 | Sale | 142 | 44.1 | 6,262 | D |
| 12 Mar 2024 13:41 | RARE | Ultragenyx Pharmaceutical Inc | KASSBERG THOMAS RICHARD | CBO & EVP | 11 Mar 2024 | Sale | 11,509 | 49.93 | 574,644 | D |
| 11 Mar 2024 12:54 | RARE | Ultragenyx Pharmaceutical Inc | FUST MATTHEW K | Director | 07 Mar 2024 | Sale | 2,145 | 50.85 | 109,073 | D |
| 11 Mar 2024 12:54 | RARE | Ultragenyx Pharmaceutical Inc | FUST MATTHEW K | Director | 07 Mar 2024 | Sale | 7,500 | 50.88 | 381,600 | D |
| 11 Mar 2024 12:54 | RARE | Ultragenyx Pharmaceutical Inc | FUST MATTHEW K | Director | 07 Mar 2024 | Sale | 2,550 | 50.89 | 129,770 | D |
| 05 Mar 2024 20:22 | RARE | Ultragenyx Pharmaceutical Inc | PARSCHAUER KARAH HERDMAN | EVP and Chief Legal Officer | 01 Mar 2024 | Sale | 3,756 | 53.76 | 201,923 | D |
| 05 Mar 2024 20:19 | RARE | Ultragenyx Pharmaceutical Inc | KASSBERG THOMAS RICHARD | CBO & EVP | 01 Mar 2024 | Sale | 1,011 | 53.76 | 54,351 | D |
| 05 Mar 2024 20:15 | RARE | Ultragenyx Pharmaceutical Inc | PINION JOHN RICHARD | See Remarks | 01 Mar 2024 | Sale | 4,173 | 53.76 | 224,340 | D |
| 05 Mar 2024 20:13 | RARE | Ultragenyx Pharmaceutical Inc | HUIZENGA THEODORE ALAN | SVP, Chief Accounting Officer | 01 Mar 2024 | Sale | 341 | 53.76 | 18,332 | D |
| 05 Mar 2024 20:10 | RARE | Ultragenyx Pharmaceutical Inc | CROMBEZ ERIC | EVP and Chief Medical Officer | 01 Mar 2024 | Sale | 1,238 | 53.76 | 66,555 | D |
| 05 Mar 2024 20:08 | RARE | Ultragenyx Pharmaceutical Inc | HARRIS ERIK | EVP & Chief Commercial Officer | 01 Mar 2024 | Sale | 4,768 | 53.76 | 256,328 | D |
| 08 Feb 2024 15:49 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 07 Feb 2024 | Sale | 30,000 | 45 | 1,350,000 | D |
| 02 Jan 2024 16:07 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 29 Dec 2023 | Sale | 30,000 | 47.87 | 1,436,100 | D |
| 24 Oct 2023 17:22 | RARE | Ultragenyx Pharmaceutical Inc | KASSBERG THOMAS RICHARD | CBO & EVP | 23 Oct 2023 | Sale | 39,878 | 32.78 | 1,307,201 | D |
| 23 Oct 2023 17:14 | RARE | Ultragenyx Pharmaceutical Inc | KAKKIS EMIL D | President & CEO | 19 Oct 2023 | Sale | 47,853 | 33.52 | 1,604,033 | D |
| 11 Sep 2023 13:52 | RARE | Ultragenyx Pharmaceutical Inc | HUIZENGA THEODORE ALAN | SVP, Chief Accounting Officer | 07 Sep 2023 | Sale | 2,000 | 41 | 82,000 | D |
| 11 Sep 2023 13:52 | RARE | Ultragenyx Pharmaceutical Inc | HUIZENGA THEODORE ALAN | SVP, Chief Accounting Officer | 07 Sep 2023 | Sale | 163 | 38.34 | 6,249 | D |
| 06 Sep 2023 17:51 | RARE | Ultragenyx Pharmaceutical Inc | HARRIS ERIK | EVP & Chief Commercial Officer | 05 Sep 2023 | Sale | 6,000 | 37.96 | 227,760 | D |
| 06 Sep 2023 17:50 | RARE | Ultragenyx Pharmaceutical Inc | HUIZENGA THEODORE ALAN | SVP, Chief Accounting Officer | 01 Sep 2023 | Sale | 87 | 38.23 | 3,326 | D |
| 06 Sep 2023 17:50 | RARE | Ultragenyx Pharmaceutical Inc | HUIZENGA THEODORE ALAN | SVP, Chief Accounting Officer | 01 Sep 2023 | Sale | 883 | 37.04 | 32,706 | D |
| 30 Jun 2023 14:34 | RARE | Ultragenyx Pharmaceutical Inc | SANDERS CORAZON (CORSEE) D. | Director | 30 Jun 2023 | Sale | 585 | 46.76 | 27,355 | D |
| 21 Jun 2023 18:17 | RARE | Ultragenyx Pharmaceutical Inc | HARRIS ERIK | EVP & Chief Commercial Officer | 19 Jun 2023 | Sale | 305 | 48.2 | 14,701 | D |
| 09 Jun 2023 14:31 | RARE | Ultragenyx Pharmaceutical Inc | SANDERS CORAZON (CORSEE) D. | Director | 08 Jun 2023 | Sale | 1,485 | 51.65 | 76,700 | D |
| 19 May 2023 13:54 | RARE | Ultragenyx Pharmaceutical Inc | PINION JOHN RICHARD | See Remarks | 18 May 2023 | Sale | 2,012 | 50 | 100,600 | D |
| 05 May 2023 14:16 | RARE | Ultragenyx Pharmaceutical Inc | PARSCHAUER KARAH HERDMAN | EVP and Chief Legal Officer | 04 May 2023 | Sale | 4,378 | 45 | 197,010 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)